Unlocking the Next Wave of Asia’s Global Biopharma Advancements

Asian biotechs—from China to Singapore, Japan to South Korea—are evolving their global strategies.

Beyond licensing, many are creating new ventures by partnering with Western investors to launch biotechs in the U.S. and Europe.

At the 5th East-West Biopharma Summit, connect with the leaders shaping Asia’s global biotech growth. Join VCs, CEOs, CFOs, and CBOs in Seoul for two days of focused networking, partnering, and discussion—where East meets West to advance innovation.

What Will I Learn?

Highlights:

Globalizing Asian Innovation: The BioCentury Scene Setter asks whether routing Asia assets to the West can be sustained, and will it result in more Asia biotechs?

The NewCo Model: The Investor Roundtable asks whether Western and Asia investors see NewCos as the best path forward to globalizing Asia's innovation?

Pharma Licensing: The Dealmakers Showcase asks pharma BD&L leaders if the wave of licensing from Asia is here to stay.

Why Should I Attend?

The East-West Summit is the leading C-level conference connecting Asian and Western biopharma executives and investors — broaden your network, engage in strategic discussions and secure the right partnerships.

Network, partner and debate with:

• VCs and PEs
• Biopharma BD&L Leaders
• Biotech C-Suite
• Family Offices
• Financial Dealmakers

Meet key players from across Asia-Pacific, including:

• Australia
• China
• Japan
• India
• South Korea
• Singapore and Southeast Asia

Deliver Thought Leadership

Share your insights, elevate your brand and position yourself as a peer in BioCentury's network of biopharma decision-makers.

Learn More